Influence of gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C

Journal of Virology

Volumn 85, Issue 8, 2011, Pages 3996-4006

  Wright, Jaclyn K ^a   Novitsky, Vladimir ^b,c   Brockman, Mark A ^d,e   Brumme, Zabrina L ^d,e   Brumme, Chanson J ^e   Carlson, Jonathan M ^f   Heckerman, David ^f   Wang, Bingxia ^g   Losina, Elena ^g   Leshwedi, Mopo ^a   Van Der Stok, Mary ^a   Maphumulo, Lungile ^a   Mkhwanazi, Nompumelelo ^a   Chonco, Fundisiwe ^a   Goulder, Philip J R ^a,h,i   Essex, Max ^b,c   Walker, Bruce D ^a,i,j   Ndung'u, Thumbi ^a,i  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d SIMON FRASER UNIVERSITY   (Canada)

^e BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^f MICROSOFT RESEARCH   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^j HOWARD HUGHES MEDICAL INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HLA B ANTIGEN; PROTEINASE;

ADULT; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADULT; DISEASE PROGRESSION; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV PROTEASE; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL LOAD; VIRULENCE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79952846443     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02520-10     Document Type: Article

References (49)

1. Abdool-Karim, Q., and S. S. Abdool Karim. 2002. The evolving HIV epidemic in South Africa. Int. J. Epidemiol. 31:37-40.
2. Ball, S. C., et al. 2003. Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. J. Virol. 77:1021-1038. (Pubitemid 36055524)
3. Brockman, M., et al. 2010. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection. J. Virol. 84:11937-11949.
4. Brockman, M. A., et al. 2007. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J. Virol. 81:12608-12618. (Pubitemid 350085874)
5. Brockman, M. A., G. O. Tanzi, B. D. Walker, and T. M. Allen. 2006. Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry. J. Virol. Methods 131:134-142.
6. Brumme, Z., et al. 2009. Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in chronic HIV-1 subtype C infection: results from Sinikithemba cohort, Durban, South Africa. Clin. Infect. Dis. 49:956-964.
7. Brumme, Z. L., et al. 2008. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J. Virol. 82:9216-9227.
8. Campbell, T. B., K. Schneider, T. Wrin, C. J. Petropoulos, and E. Connick. 2003. Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma. J. Virol. 77:12105-12112. (Pubitemid 37339863)
9. Carrington, M., and S. J. O'Brien. 2003. The influence of HLA genotype on AIDS. Annu. Rev. Med. 54:535-551.
10. Chopera, D. R., et al. 2008. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS Pathog. 4:e1000033.
11. Crawford, H., et al. 2009. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. J. Exp. Med. 206:909-919.
12. + T-cell escape mutations and covarying HLA-independent polymorphisms. J. Virol. 85:1384-1390.
13. Derdeyn, C. A., and G. Silvestri. 2005. Viral and host factors in the pathogenesis of HIV infection. Curr. Opin. Immunol. 17:366-373.
14. Duda, A., et al. 2009. HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection. J. Virol. 83:1228-1239.
15. Fiebig, E. W., et al. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17:1871-1879. (Pubitemid 37070272)
16. Gao, X., et al. 2005. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat. Med. 11:1290-1292.
17. Goepfert, P. A., et al. 2008. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J. Exp. Med. 205:1009-1017.
18. Goonetilleke, N., et al. 2009. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J. Exp. Med. 206:1253-1272.
19. Huang, X., and J. Zhang. 1996. Methods for comparing a DNA sequence with a protein sequence. Comput. Appl. Biosci. 12:497-506.
20. Hunter, E., et al. 2009. Abstr. AIDS Vaccine 2009 Conf., abstr. S05-01.
21. Kawashima, Y., et al. 2009. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458:641-645.
22. Kiepiela, P., et al. 2004. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432:769-774.
23. Langford, S. E., J. Ananworanich, and D. A. Cooper. 2007. Predictors of disease progression in HIV infection: a review. AIDS Res. Ther. 4:11.
24. Lassen, K. G., et al. 2009. Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics. PLoS Pathog. 5:e1000377.
25. Marozsan, A. J., et al. 2005. Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry. J. Virol. 79:7121-7134. (Pubitemid 40684493)
26. Martinez-Picado, J., et al. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80:3617-3623.
27. Matthews, P. C., et al. 2008. Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J. Virol. 82:8548-8559.
28. Miura, T., et al. 2009. HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1. J. Virol. 83:140-149.
29. Miura, T., et al. 2010. Impaired replication capacity of acute/early viruses in persons who become HIV controllers. J. Virol. 84:7581-7591.
30. Mothe, B., J. Ibarrondo, A. Llano, and C. Brander. 2009. Virological, immune and host genetics markers in the control of HIV infection. Dis. Markers 27:105-120.
31. Ngumbela, K. C., et al. 2008. Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. AIDS Res. Hum. Retroviruses 24:72-82.
32. Novitsky, V., et al. 2009. Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection. J. Acquir. Immune Defic. Syndr. 52:265-272.
33. Novitsky, V., et al. 2009. Timing constraints of in vivo Gag mutations during primary HIV-1 subtype C infection. PLoS One 4:e7727.
34. + T cell dynamics in primary HIV-1 subtype C infection. J. Acquir. Immune Defic. Syndr. 50:65-76.
35. Pereyra, F., et. al, for the International HIV Controllers Study. 2010. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330:1551-1557. doi:10.1126/science.1195271.
36. Prado, J. G., et al. 2010. Replicative capacity of human immunodeficiency virus Type 1 transmitted from mother to child is associated with pediatric HIV-1 disease progression rate. J. Virol. 84:492-502.
37. Quiñones-Mateu, M. E., et al. 2000. A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression. J. Virol. 74:9222-9233.
38. Rolland, M., et al. 2008. Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads. PLoS One 3:e1424. doi:10.1371/journal. pone.0001424.
39. Schaefer, M., et al. 2009. Abstr. AIDS Vaccine 2009 Conf., abstr. OA06-03.
40. Schneidewind, A., et al. 2008. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid. J. Virol. 82:5594-5605. (Pubitemid 351705266)
41. Schneidewind, A., et al. 2007. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J. Virol. 81:12382-12393. (Pubitemid 350085852)
42. Schneidewind, A., et al. 2009. Maternal transmission of human immunodeficiency virus escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant. J. Virol. 83:8616-8627.
43. Sterling, T. R., et al. 2001. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N. Engl. J. Med. 344:720-725.
44. Storey, J. D., and R. Tibshirani. 2003. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. U. S. A. 100:9440-9445.
45. Tang, J., et al. 2002. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J. Virol. 76:8276-8284. (Pubitemid 34809082)
46. Thobakgale, C. F., et al. 2009. Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection. J. Virol. 83:10234-110244.
47. + T-cell activity is detectable from birth in the majority of in uteroinfected infants. J. Virol. 81:12775-12784.
48. van Loggerenberg, F., et al. 2008. Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study. PLoS One 3:e1954.
49. Wright, J. K., et al. 2010. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters. J. Virol. 84:10820-10831.